Related Experiment Video
Updated: Aug 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription
Steven A Innocente1, Jonathan M Lee
1Hamilton Regional Cancer Centre, Hamilton, Ont., Canada.
Abstract:
The p53 tumour suppressor protein is a DNA-binding transcription factor activated in response to DNA damage. Inactivation of the p53 gene occurs in 40-60% of human tumours and a substantial body of work indicates that loss of p53 activity is a critical step in oncogenesis. p53 helps to protect against neoplasia by inducing death in cells that have sustained irreparable DNA damage or by blocking cell cycle progression to allow time for DNA repair. We have previously reported that p53 prevents G2/M transition by decreasing intracellular levels of cyclin B1 protein and attenuating the activity of the cyclin B1 promoter [S.A. Innocente, J.L. Abrahamson, J.P. Cogswell, J.M. Lee, p53 regulates a G2 checkpoint through cyclin B1, Proc. Natl. Acad. Sci. USA 96 (1999) 2147-2152]. The ability of p53 to control mitotic initiation by regulating intracellular cyclin B1 levels suggests that a cyclin B1-dependent G2 checkpoint has a role in preventing neoplastic transformation. Here, we show that p53-mediated attenuation of the cyclin B1 promoter occurs in both p21+/+ and p21-/- cell lines. Furthermore, promoter attenuation is dependent on the presence of functional Sp1 binding sites and is independent of the NF-Y binding sites. We also find that wild-type, but not mutant, p53 protein binds Sp1 and the cyclin B1 promoter. This suggests that wild-type p53 mediates transcriptional repression of cyclin B1 through the Sp1 transcription factor.
Insights
The p53 tumor suppressor protein prevents cell cycle G2/M transition by regulating cyclin B1. Wild-type p53 binds Sp1 and the cyclin B1 promoter, suggesting a mechanism for preventing tumor formation.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The p53 tumor suppressor protein is crucial for preventing cancer by inducing cell death or blocking cell cycle progression in response to DNA damage.
- Inactivation of the p53 gene is common in human tumors, highlighting its role in oncogenesis.
- p53 regulates the G2/M cell cycle transition via control of cyclin B1 levels and promoter activity.
Purpose of the Study:
- To investigate the mechanism by which p53 mediates transcriptional repression of the cyclin B1 promoter.
- To determine the role of Sp1 and NF-Y transcription factors in p53-mediated regulation of cyclin B1.
- To explore the interaction between wild-type p53, Sp1, and the cyclin B1 promoter.
Main Methods:
- Analysis of cyclin B1 promoter activity in p21+/+ and p21-/- cell lines.
- Mutation analysis of Sp1 and NF-Y binding sites within the cyclin B1 promoter.
- Co-immunoprecipitation assays to assess the binding of wild-type and mutant p53 to Sp1 and the cyclin B1 promoter.
Main Results:
- p53-mediated attenuation of the cyclin B1 promoter was observed in both p21+/+ and p21-/- cells.
- Cyclin B1 promoter repression by p53 required functional Sp1 binding sites but not NF-Y binding sites.
- Wild-type p53, but not mutant p53, directly bound to Sp1 and the cyclin B1 promoter.
Conclusions:
- Wild-type p53 represses cyclin B1 transcription through interaction with the Sp1 transcription factor.
- This p53-Sp1-cyclin B1 regulatory pathway is a key mechanism by which p53 acts as a tumor suppressor.
- Understanding this pathway offers potential therapeutic targets for cancer treatment.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

